Affordability Check
How to afford IMATINIB MESYLATE
Generic name: imatinib mesylate
Pick how you're covered. We'll show you the cheapest legitimate way to get IMATINIB MESYLATE — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About IMATINIB MESYLATE and its cost
What is this medication? Imatinib mesylate is a prescription medication primarily used to treat certain types of cancer, most notably chronic myeloid leukemia and acute lymphoblastic leukemia. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by targeting and blocking specific proteins that signal cancer cells to grow and divide. By inhibiting these signals, the medication helps to stop the spread of malignant cells and can lead to a reduction in the overall tumor burden within the body.
In addition to its use in treating blood-related cancers, this medication is also approved for the treatment of gastrointestinal stromal tumors. These are rare tumors that originate in the walls of the digestive tract. It may also be prescribed for other rare conditions, such as systemic mastocytosis or certain skin cancers like dermatofibrosarcoma protuberans. Unlike traditional chemotherapy that affects all rapidly dividing cells, imatinib mesylate is considered a targeted therapy because it focuses more specifically on the molecular changes that drive the growth of specific types of cancer cells.
IMATINIB MESYLATE is made by a pharmaceutical manufacturer. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford IMATINIB MESYLATE?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for IMATINIB MESYLATE?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But the manufacturer has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover IMATINIB MESYLATE?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Acute Lymphoblastic Leukemia?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about IMATINIB MESYLATE
Full IMATINIB MESYLATE drug page
FDA label, prior authorization rules, full indications list
More options for Acute Lymphoblastic Leukemia
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3